Named Patient Medicines

Mitotane is also known as lysodren. It is used to treat a rare cancer of the adrenal glands called adrenal cortical carcinoma. Mitotane (Lysodren) is used to treat a rare cancer of the adrenal glands called adrenal cortical carcinoma. It is best to read this information along with our general information about chemotherapy. Before you agree to treatment (consent) your doctor will talk to you about this treatment and its possible side effects. This is what we mean when we refer to doctor, nurse or pharmacist in this information. Mitotane (Lysodren) You take mitotane as pills. You can also take this with other cancer treatments by the advice of the physician. The nurse or pharmacist will give you mitotane tablets to take at home. Always take your pills exactly as told by the nurse or pharmacist. It's important to make sure they work for you as well as possible. The nurse or pharmacist can give you a copy of the treatment plan to take home with you. Mitotane tablets usually taken 2

The use of alogliptin is accompanied by various side effects. These side effects may be mild or severe, temporary or permanent. However, there are some precautions that should be taken while using this medicine. These include: dosage, precautions, indications, and drug interactions. In order to avoid such complications, consult your physician. If you are taking a prescription drug, you should check the Alogliptin brand name check uses side effects interactions Dosage Alogliptin is a type 2 diabetes drug prescribed to treat high blood sugar. It is contraindicated for patients with type 1 diabetes, acute pancreatitis, and renal impairment. Alogliptin is a prescription medication that requires a doctor's supervision. Patients should also follow a healthy diet and exercise program while taking this medication. Common side effects of Alogliptin include nausea, indigestion, and flatulence. The drug works by increasing the amount of insulin in the blood. It reduces both postprandial gluc

What is a  Mekinist ? Mekinist is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Mekinist is used alone or with another medicine called dabrafenib (Tafinlar) to treat certain types of cancer in people with a "BRAF" gene mutation. Mechanist is for use in the treatment of: Mekinist • Melanoma (skin cancer) that cannot be treated with surgery or has spread to other parts of the body, or to prevent melanoma from coming back after surgery; • non-small cell lung cancer that has spread to other parts of the body; either • Advanced or metastatic thyroid cancer that has spread and for which there are no other treatment options. Warning Using Mekinist with dabrafenib may increase your risk of developing a certain type of skin cancer. Ask your doctor about your specific risk. Tell your doctor if you notice new skin symptoms such as redness, warts, sores that will not heal, or a mole that has changed in size or color. Follow all instructions on

To treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). ·          Azacitidine, or decitabine, or in combination with low-dose cytarabine for the treatment of adults with newly diagnosed acute myeloid leukemia (AML): o    are 75 years of age or older, or o    There are other medical conditions that preclude the use of standard chemotherapy. It is not known whether VENCLEXTA is safe and effective in children. Important Safety Information What is the most important information I should know about Venclexta? VENCLEXTA can cause serious side effects, including: Tumor lysis syndrome (TLS) . TLS is caused by the rapid breakdown of cancer cells. TLS can lead to kidney failure, the need for dialysis treatment, and death. Your healthcare provider will perform tests to check your risk of getting TLS before you start taking Venclexta. You will receive other medicines before and during treatment with Venclexta to help reduce your risk of TLS.

  In a clinical trial, half of patients with metastatic colon or rectal cancer treated with LONSURF® (trifluridine and tipiracil) Tablets were still alive at 7.1 months and half of patients who received placebo were still alive at 5.3 months were alive. Worsening of disease or death occurred in 88% of patients treated with LONSURF and 94% of patients receiving placebo. In the clinical trial, half of the patients with metastatic colon cancer treated with LONSURF were still alive at 5.7 months and half of the patients who received placebo were still alive at 3.6 months. Worsening of disease or death occurred in 85% of patients treated with LONSURF and 92% of patients receiving placebo.   Signs and important safety information LONSURF is a prescription medicine used to treat adults • Colorectal cancer that has spread to other parts of the body and has been previously treated or cannot receive certain chemotherapy drugs. • A type of stomach cancer called gastric cancer, includ

What is ZELBORAF approved for? ZELBORAF is a medicine used to treat a type of skin cancer called melanoma that has spread to other parts of the body or cannot be removed by surgery, and contains a certain type of abnormal "BRAF" gene. Is. Zelboraf is not used to treat melanoma with the normal BRAF gene. Your healthcare provider will perform a test to make sure ZELBORAF is right for you. ZELBORAF is a prescription medicine used to treat a type of blood cell cancer called Erdheim-Chester disease (ECD), which can affect the body's tissues and organs, and includes a certain type of abnormal "BRAF" "Gene is there. It is not known whether Zelboraf is safe and effective in children under 18 years of age. Important Safety Information What is the most important information I should know about Zelboraf? ZELBORAF can cause serious side effects, including: New cancer risk. ZELBORAF may cause certain types of skin cancer called cutaneous squamous cell ca